Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.



Identification and molecular docking study of fish roe-derived peptidesas potent BACE 1, AChE and BChE inhibitors

Abstract

Acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and beta-secretase 1(BACE 1) play vital roles in the development and progression of Alzheimer’s disease (AD). The objective of the present study was to identify fish roe-derived anti-AD peptides with activities against AChE, BChE, and BACE 1. Fish roe proteins were in silico cleaved by gastrointestinal proteases, and released peptides were collected. Subsequently, the toxicity, solubility, and biological properties of these novel di- and tri-peptides were predicted and validated. Finally, potential anti-AD peptides were docked to targets, i.e., AChE, BChE, and BACE 1. As a result, a novel anti-AD tripeptide WIR with potent AChE and BACE 1 inhibitory activity was identified, with IC50 value of 43.32±1.22 μM and 2.27±0.35 mM, respectively. In addition, the inhibition rate of WIR (at the concentration of 1.06±0.87 µM) against BChE was 33.5%. And the peptide WIR was able to interact with AChE, BChE and BACE 1simultaneously. Especially, residues Ser286 of AChE, Asp70 of BChE, and Thr231, Arg235 of BACE 1 played key role in the interaction of peptide WIR. In summary, peptide WIR has the potential to be a candidate for the treatment of AD.

Back to tab navigation

Article information


Submitted
15 Apr 2020
Accepted
19 Jun 2020
First published
25 Jun 2020

Food Funct., 2020, Accepted Manuscript
Article type
Paper

Identification and molecular docking study of fish roe-derived peptidesas potent BACE 1, AChE and BChE inhibitors

Z. Yu, H. Ji, J. SHEN, R. KAN, W. Zhao, J. Li, L. DING and J. Liu, Food Funct., 2020, Accepted Manuscript , DOI: 10.1039/D0FO00971G

Social activity

Search articles by author

Spotlight

Advertisements